To further explore the mechanism by which IGF2BP2 promotes HBV‐HCC tumorigenicity, we used bioinformatics analysis (https://starbase.sysu.edu.cn) to screen several downstream genes associated with HCC that can bind to IGF2BP2. The gene discussed is IGF2BP2; the disease is hepatocellular carcinoma.